Smart Money Alert

Sudeep Pharma Limited

New PositionBlock Deal

SUDEEPPHRMPharmaceuticalsMarket Cap₹14K Cr

Deal value

₹100.00 Cr

Deal price

₹850.00

11.76 L

Trade date

4 Aug 2026

Since alert+26.2%₹958.95 → ₹1,210.30

Nifty 50+1.7%

Goldman Sachs

Foreign Investor

The move

Goldman Sachs bought 1,176,472 shares of Sudeep Pharma Limited for ₹100.00 crore at ₹850.00 apiece in a block deal.

About Sudeep Pharma Limited

+ Follow Visit stock

A pharmaceutical excipient manufacturer established in 1989, Sudeep Pharma produces high-quality ingredients for medications, food-grade minerals, and specialty nutrition products. The company serves pharmaceutical, nutritional, and food industries across more than 100 countries worldwide. Its vertically integrated operations focus on delivering consistent quality, reliability, and technical support to global pharmaceutical and nutrition clients.

About Goldman Sachs

+ Follow Visit investor

US-based global investment bank (USD 1.6 trillion in assets, USD 3 trillion+ in client AUM through Goldman Sachs Asset Management). India FPI activity covers proprietary, market-making, client flows and active asset management mandates in listed Indian equities.

Get the next move the moment it happens.

Follow Goldman Sachs and Sudeep Pharma Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Sudeep Pharma Limited shareholders Goldman Sachs's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Sudeep Pharma Limited

Axis Mutual FundDecreased

Axis Mutual Fund trimmed its stake in Sudeep Pharma from 1.85% to 1.81%, selling 44,579 shares.

9 Oct 2026

SBI Mutual FundIncreased

SBI Mutual Fund increased its stake in Sudeep Pharma Limited from 1.20% to 2.85%, purchasing 18,55,590 shares. Based on the current share price of ₹1050.30, the additional acquisition is valued at approximately ₹194.89 Cr.